Nexgen biotechnologies, inc. is a leading plant biotechnology company establised in 1999 as a venture company based on and specialized in the platform technology of 2nd generation plant biotechnology.

Since its inception, the company has been focused on advancing the next generation of biotechnology to supply the high quality product with low cost.

We are an unique manufacturer acquired GH (Good Health) Mark for EGF from Korean Government (the Korea Health Industry Development Institute) in 2009 and

it shows we are the leader in Korea when it comes to EGF.

In addition to EGF as a raw material, we have recently started producing cosme-

ceutical products such as skin lotion, cream, gel, and essence for reactivating, lifting, and whitening in accordance with customers' request (i.e.Clinic,m Esthetic, Consumer).

Nexgen conducts research and development in various fields: Molecular farming for the production of useful proteins using plants as bio-factories, developing edible vaccines for oral vaccinations against particular diseases, phytoremediation research for cleaning pollutants from the air, soil or water as well as being involved with floriculture for producing virus-free plants. Through its concentrated research efforts nexgen is developing high value-added medicines, cosmetics and industrial enzymes.

TEL. : +82-2-857-1671

FAX. : +82-2-857-1674